Immunization Newsbriefs (c) Copyright Information
Inc., Bethesda, MD. Brought to you by the National Network for Immunization
Information (NNii). Visit NNii's new website at
http://www.immunizationinfo.org.
A University of California-Los Angeles study
finds that a vaccine candidate could cease the progression of type 1 diabetes in
patients who already have the disease. The product specifically boosts a
persons ability to make insulin. A diagnostic test was used to find
individuals whose diabetes was likely caused by antibodies to the GAD protein in
the pancreas insulin-producing cells, the most likely candidates for the
vaccine. Diamyd Medical, which has licensed the vaccine research, believes the
vaccines first use will be to help patients not become dependent on injections
of insulin.
DISCLAIMER: All
information, data, and material contained, presented, or provided here is for
general information purposes only and is not to be construed as reflecting the
knowledge or opinions of the publisher, and is not to be construed or intended
as providing medical or legal advice. The decision whether or not to vaccinate
is an important and complex issue and should be made by you, and you alone, in
consultation with your health care provider.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"